-
1
-
-
0037465153
-
Validation of liquid chromatography assay for the quantitation of (Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl) -1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial
-
Asad Y, Cropp G, Adams A, O'Donnell A, Raynaud F, Judson I, and Workman P (2003) Validation of liquid chromatography assay for the quantitation of (Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl) -1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial. J Chromatogr B Analyt Technol Biomed Life Sci 785:175-186.
-
(2003)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.785
, pp. 175-186
-
-
Asad, Y.1
Cropp, G.2
Adams, A.3
O'Donnell, A.4
Raynaud, F.5
Judson, I.6
Workman, P.7
-
2
-
-
0001182986
-
A phase I study of SU6668 in patients with refractory solid tumors
-
Abstract 335
-
Brahmer JR, Kelsey S, Scigalla P, Hill G, Bello C, Elza-Brown K, and Donehower R (2002) A phase I study of SU6668 in patients with refractory solid tumors. Proc Am Soc Clin Oncol 21:Abstract 335.
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Brahmer, J.R.1
Kelsey, S.2
Scigalla, P.3
Hill, G.4
Bello, C.5
Elza-Brown, K.6
Donehower, R.7
-
3
-
-
0032852528
-
Molecular and biological properties of vascular endothelial growth factor
-
Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527-543.
-
(1999)
J Mol Med
, vol.77
, pp. 527-543
-
-
Ferrara, N.1
-
4
-
-
0032927254
-
Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications
-
Fleisher D, Li C, Zhou Y, Pao LH, and Karim A (1999) Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet 36:233-254.
-
(1999)
Clin Pharmacokinet
, vol.36
, pp. 233-254
-
-
Fleisher, D.1
Li, C.2
Zhou, Y.3
Pao, L.H.4
Karim, A.5
-
5
-
-
0033556802
-
Signal transduction by fibroblast growth factor receptors
-
Klint P and Claesson-Welsh L (1999) Signal transduction by fibroblast growth factor receptors. Front Biosci 4:165-177.
-
(1999)
Front Biosci
, vol.4
, pp. 165-177
-
-
Klint, P.1
Claesson-Welsh, L.2
-
6
-
-
24344465796
-
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies
-
Kuenen BC, Giaccone G, Ruijter R, Kok A, Schalkwijk C, Hoekman K, and Pinedo HM (2005) Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies. Clin Cancer Res 11:6240-6246.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6240-6246
-
-
Kuenen, B.C.1
Giaccone, G.2
Ruijter, R.3
Kok, A.4
Schalkwijk, C.5
Hoekman, K.6
Pinedo, H.M.7
-
7
-
-
0033567424
-
Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO-1) expression and modulation of δ-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats
-
Iba MM, Alam J, Touchard C, Thomas PE, Ghosal A, Fung J (1999) Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO-1) expression and modulation of δ-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats. Biochem Pharmacol 58:723-734.
-
(1999)
Biochem Pharmacol
, vol.58
, pp. 723-734
-
-
Iba, M.M.1
Alam, J.2
Touchard, C.3
Thomas, P.E.4
Ghosal, A.5
Fung, J.6
-
8
-
-
0036304016
-
Pharmacokinetic interactions between herbal remedies and medicinal drugs
-
Ioannides C (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32:451-478.
-
(2002)
Xenobiotica
, vol.32
, pp. 451-478
-
-
Ioannides, C.1
-
9
-
-
0033883776
-
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
-
Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, et al. (2000) SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res 60:4152-4160.
-
(2000)
Cancer Res
, vol.60
, pp. 4152-4160
-
-
Laird, A.D.1
Vajkoczy, P.2
Shawver, L.K.3
Thurnher, A.4
Liang, C.5
Mohammadi, M.6
Schlessinger, J.7
Ullrich, A.8
Hubbard, S.R.9
Blake, R.A.10
-
10
-
-
1242269897
-
Rifampicin reduces plasma concentrations of celiprolol
-
Lilja JJ, Niemi M, and Neuvonen PJ (2004) Rifampicin reduces plasma concentrations of celiprolol. Eur J Clin Pharmacol 59:819-824.
-
(2004)
Eur J Clin Pharmacol
, vol.59
, pp. 819-824
-
-
Lilja, J.J.1
Niemi, M.2
Neuvonen, P.J.3
-
11
-
-
33745395225
-
CYP induction-mediated drug interactions: In vitro assessment and clinical implications
-
Lin JH (2006) CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res (NY) 23:1089-1116.
-
(2006)
Pharm Res (NY)
, vol.23
, pp. 1089-1116
-
-
Lin, J.H.1
-
12
-
-
0141765335
-
Phase I, pharmacokinetic, and biological studies of TSU-68, the oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, administered after meals in patients with advanced solid tumors
-
Abstract 870
-
Murakami H, Yamamoto N., Shimoyama T, Ueda Y, Yamada Y, and Tamura T (2003) Phase I, pharmacokinetic, and biological studies of TSU-68, the oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, administered after meals in patients with advanced solid tumors. Proc Am Soc Clin Oncol 22:Abstract 870.
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
-
-
Murakami, H.1
Yamamoto, N.2
Shimoyama, T.3
Ueda, Y.4
Yamada, Y.5
Tamura, T.6
-
13
-
-
0034029871
-
Auto-induction of E5110 metabolism, a novel non-steroidal anti-inflammatory drug, during toxicokinetic studies in beagle dogs
-
Nakata H, Sagami F, and Horie T (2000) Auto-induction of E5110 metabolism, a novel non-steroidal anti-inflammatory drug, during toxicokinetic studies in beagle dogs. J Toxicol Sci 25:1-10.
-
(2000)
J Toxicol Sci
, vol.25
, pp. 1-10
-
-
Nakata, H.1
Sagami, F.2
Horie, T.3
-
14
-
-
0035154160
-
Application of rat hepatocyte culture to predict in vivo metabolic autoinduction: Studies with DFP, a cyclooxygenase-2 inhibitor
-
Nicoll-Griffith DA, Silva JM, Chauret N, Day S, Leblanc Y, Roy P, Yergey JA, Dixit R, and Patrick D (2001) Application of rat hepatocyte culture to predict in vivo metabolic autoinduction: studies with DFP, a cyclooxygenase-2 inhibitor. Drug Metab Dispos 29:159-165.
-
(2001)
Drug Metab Dispos
, vol.29
, pp. 159-165
-
-
Nicoll-Griffith, D.A.1
Silva, J.M.2
Chauret, N.3
Day, S.4
Leblanc, Y.5
Roy, P.6
Yergey, J.A.7
Dixit, R.8
Patrick, D.9
-
15
-
-
0032733974
-
Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes
-
Obach RS (1999) Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350-1359.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 1350-1359
-
-
Obach, R.S.1
-
16
-
-
0344938358
-
Inhibition and induction of human cytochrome P450 (CYP) enzymes
-
Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, and Raunio H (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203-1253.
-
(1998)
Xenobiotica
, vol.28
, pp. 1203-1253
-
-
Pelkonen, O.1
Mäenpää, J.2
Taavitsainen, P.3
Rautio, A.4
Raunio, H.5
-
17
-
-
0032462002
-
Evidence for distinct signaling properties and biological responses induced by the PDGF receptor α and β subtypes
-
Rosenkranz S and Kazlauskas A (1999) Evidence for distinct signaling properties and biological responses induced by the PDGF receptor α and β subtypes. Growth Factors 16:201-216.
-
(1999)
Growth Factors
, vol.16
, pp. 201-216
-
-
Rosenkranz, S.1
Kazlauskas, A.2
-
18
-
-
4043078544
-
Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats
-
Saadeddin A, Torres-Molina F, Cárcel-Trullols J, Araico A, and Peris JE (2004) Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats. AAPS PharmSci 6:E1.
-
(2004)
AAPS PharmSci
, vol.6
-
-
Saadeddin, A.1
Torres-Molina, F.2
Cárcel-Trullols, J.3
Araico, A.4
Peris, J.E.5
-
19
-
-
30544448281
-
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing
-
Sessa C, Viganò L, Grasselli G, Trigo J, Marimon I, Lladò A, Locatelli A, Ielmini N, Marsoni S, and Gianni L (2006) Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing. Eur J Cancer 42:171-178.
-
(2006)
Eur J Cancer
, vol.42
, pp. 171-178
-
-
Sessa, C.1
Viganò, L.2
Grasselli, G.3
Trigo, J.4
Marimon, I.5
Lladò, A.6
Locatelli, A.7
Ielmini, N.8
Marsoni, S.9
Gianni, L.10
-
20
-
-
33646801604
-
Autoinduction of MKC-963 [(R)-1-(1-cyclohexylethylamino)- 4-phenylphthalazine] metabolism in healthy volunteers and its retrospective evaluation using primary human hepatocytes and cDNA-expressed enzymes
-
Shimizu T, Akimoto K, Yoshimura T, Niwa T, Kobayashi K, Tsunoo M, and Chiba K (2006) Autoinduction of MKC-963 [(R)-1-(1-cyclohexylethylamino)- 4-phenylphthalazine] metabolism in healthy volunteers and its retrospective evaluation using primary human hepatocytes and cDNA-expressed enzymes. Drug Metab Dispos 34:950-954.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 950-954
-
-
Shimizu, T.1
Akimoto, K.2
Yoshimura, T.3
Niwa, T.4
Kobayashi, K.5
Tsunoo, M.6
Chiba, K.7
-
21
-
-
0031748173
-
In vitro and in vivo drug interactions involving human CYP3A
-
Thummel KE and Wilkinson GR (1998) In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 38:389-430.
-
(1998)
Annu Rev Pharmacol Toxicol
, vol.38
, pp. 389-430
-
-
Thummel, K.E.1
Wilkinson, G.R.2
-
23
-
-
0033753435
-
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction
-
Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, et al. (2000) Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin Pharmacol Ther 68:345-355.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 345-355
-
-
Westphal, K.1
Weinbrenner, A.2
Zschiesche, M.3
Franke, G.4
Knoke, M.5
Oertel, R.6
Fritz, P.7
von Richter, O.8
Warzok, R.9
Hachenberg, T.10
-
24
-
-
10244266374
-
A phase I surrogate endpoint study of SU6668 in patients with solid tumors
-
Xiong HQ, Herbst R, Faria SC, Scholz C, Davis D, Jackson EF, Madden T, McConkey D, Hicks M, Hess K, et al. (2004) A phase I surrogate endpoint study of SU6668 in patients with solid tumors. Invest New Drugs 22:459-466.
-
(2004)
Invest New Drugs
, vol.22
, pp. 459-466
-
-
Xiong, H.Q.1
Herbst, R.2
Faria, S.C.3
Scholz, C.4
Davis, D.5
Jackson, E.F.6
Madden, T.7
McConkey, D.8
Hicks, M.9
Hess, K.10
-
25
-
-
0031013537
-
Regulation of cytochrome P4501A1 expression in rat small intestine
-
Zhang QY, Wikoff J, Dunbar D, Fasco M, and Kaminsky L (1997) Regulation of cytochrome P4501A1 expression in rat small intestine. Drug Metab Dispos 25:21-26.
-
(1997)
Drug Metab Dispos
, vol.25
, pp. 21-26
-
-
Zhang, Q.Y.1
Wikoff, J.2
Dunbar, D.3
Fasco, M.4
Kaminsky, L.5
|